Your session is about to expire
← Back to Search
Lisdexamfetamine for ADHD
This trial will test the effect of Lisdexamfetamine dimesylate on children and adolescents with ADHD and comorbid Autism Spectrum Disorder.
- Autism Spectrum Disorder
- Attention Deficit Hyperactivity Disorder (ADHD)
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2011 Phase 4 trial • 26 Patients • NCT01071044
Awards & Highlights
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment open for this clinical experiment?
"Affirmative. According to data hosted on clinicaltrials.gov, this medical research is presently seeking volunteers and was initially posted in September of 2018. The most recent update occurred at the end of March 2021 with 40 patients needed from 1 site."
How many participants are being included in this medical experiment?
"Affirmative. Data from clinicaltrials.gov indicates that this study, which was initially made available on September 26th 2018, is actively recruiting volunteers. Approximately 40 people are needed to be sourced at a single medical site."
Is this endeavor the pioneering study of its type?
"Research into this therapeutic option has been ongoing since 2018, beginning with an initial trial sponsored by Shire. This clinical study was successful enough to warrant Phase 4 drug approval and today there are 6 active trials occurring across 3 cities in 3 different countries."
Has this therapeutic approach been tested in similar scenarios?
"Presently, 6 different medical trials are underway studying this intervention with 3 of them in their final stage. In addition to Iowa City, Iowa there are 5 other locations conducting clinical studies for the treatment."
Is the cut-off age for this experiment 55 years old or younger?
"To be included in this trial, participants must have an age between 6 to 12. According to the data, there are 519 trials conducted for patients below 18 years old and another 681 clinical studies designed for elderly people above 65."
What potential adverse effects could be experienced by those undergoing this treatment?
"By virtue of being a Phase 4 trial, the safety of this medical intervention is estimated to be 3 on our 1-3 scale. This indicates that there is ample evidence to support its approval for use."
Do I meet the criteria to enroll in this clinical trial?
"To be eligible for this research, those with autism spectrum disorder must fall between the ages of 6 to 12. The team are expecting 40 people to join their investigation."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends